Clinical Trial Update: A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943 [Phase 1]

View source ↗

Summary

A Phase 1 study in adults with obesity evaluating calorie consumption and energy usage following LY3437943 dosing; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• LY3437943

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity | Phase 1 | Status: COMPLETED